NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000025445

Registered date:10/01/2017

13C-glucose breath test for evaluation of glucose metabolism in patients with fatty liver

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedfatty liver disease
Date of first enrollment2017/03/01
Target sample size40
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)100mg of 13C-glucose + 50mL of water is administerd, thereafter breaths are collected. The frequency of 13C-glucose administration is once.

Outcome(s)

Primary Outcome13CO2 in breath at the time of breath test.
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximum80years-old
GenderMale and Female
Include criteria
Exclude criteriapregnancy and lactating women

Related Information

Contact

public contact
Name Shojiro Sawada
Address Seiryo 1-1, Aoba, Sendai, Miyagi Japan 980
Telephone 022-717-7611
E-mail ssawada@med.tohoku.ac.jp
Affiliation Tohoku Universuty Hospital Dept of Diabetes and Metabolism
scientific contact
Name Hideki Katagiri
Address Seiryo 1-1, Aoba, Sendai, Miyagi Japan
Telephone 022-717-7611
E-mail hisyodm@med.tohoku.ac.jp
Affiliation Tohoku Universuty Hospital Dept of Diabetes and Metabolism